ArticleCureus2022

Prolonged Response of Metastatic Programmed Death-Ligand 1 (PD-L1) Negative Basaloid Squamous Cell Carcinoma of the Lung to Maintenance Immunotherapy.

Ashley D Fox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.